当前位置：首页 > 文献互助 > 互助详情

期刊论文IPO9 Promotes Ovarian Cancer Progression by Suppressing HMOX1‐Dependent Ferroptosis复制

用户q0-AZlKCTUkA 1个月前 86 已完结

1. 系统已在2026-02-16 09:34:15对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1155/humu/8545131 复制

文献链接: https://onlinelibrary.wiley.com/doi/10.1155/humu/8545131复制

其他信息:

出版社: Wiley
作者: Yimei Meng; Peiling Li
全文下载地址: https://onlinelibrary.wiley.com/doi/pdf/10.1155/humu/8545131

上一篇：Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer

下一篇：放射性核素偶联药物的非临床安全性评价关注要点

互助时间线

2026-02-13 20:31:19 [完结求助]

系统完结了求助, 已自动确认了小星星123应助的文件是正确的, 求助状态变成已完结

2026-02-09 09:34:15 [上传文件]

小星星123上传了文件(pdf 9.62 MB), 求助状态变成待确认

2026-02-08 20:31:19 [发起求助]

最新发布的求助

Cost-Effectiveness Analysis of Anlotinib Plus Penpulimab Versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma in China 3分钟前

Reduction of Aldehydes with Formic acid in Ethanol using Immobilized Iridium Nanoparticles on a Triazine‐phosphanimine Polymeric Organic Support 8分钟前

Mechanical signaling via β2 integrin decouples T cell proliferation and differentiation for generating stem cell-like CAR T cells 9分钟前

Cost-effectiveness of first-line immune checkpoint inhibitor therapies, alone or combined with targeted agents, for unresectable hepatocellular carcinoma in China: an economic evaluation using network meta-analysis 9分钟前

Cost-Effectiveness Analysis of Anlotinib Plus Penpulimab Versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma in China 9分钟前

Anlotinib and penpulimab in advanced hepatocellular carcinoma: a new contender emerges 11分钟前

Biaxially strained PtPb/Pt core/shell nanoplate boosts oxygen reduction catalysis 15分钟前

Dual-core drive hydrogen transfer heterogeneous catalysts based on iridium-enzyme co-modified carbon nanotubes for aromatic aldehyde hydrogenation 34分钟前

… HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026 36分钟前

Kinetics of the acid-catalyzed closure of hydantoic acids. Effect of 2-aryl and 2-alkyl substituents 1小时前

Molnupiravir is not a Selective CES2 Probe Substrate: In Vitro Evidence for CES1 Involvement 1小时前

Patent landscape and therapeutic evolution of Mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes 2小时前